Annual Operating Expenses
$26.12 B
-$800.00 M-2.97%
December 31, 2023
Summary
- As of February 7, 2025, BMY annual total operating expenses is $26.12 billion, with the most recent change of -$800.00 million (-2.97%) on December 31, 2023.
- During the last 3 years, BMY annual operating expenses has fallen by -$2.45 billion (-8.58%).
- BMY annual operating expenses is now -8.58% below its all-time high of $28.57 billion, reached on December 31, 2020.
Performance
BMY Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$6.76 B
-$480.00 M-6.63%
September 30, 2024
Summary
- As of February 7, 2025, BMY quarterly total operating expenses is $6.76 billion, with the most recent change of -$480.00 million (-6.63%) on September 30, 2024.
- Over the past year, BMY quarterly operating expenses has dropped by -$66.00 million (-0.97%).
- BMY quarterly operating expenses is now -24.83% below its all-time high of $9.00 billion, reached on December 31, 2020.
Performance
BMY Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
BMY Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.0% | -1.0% |
| 3 y3 years | -8.6% | -1.0% |
| 5 y5 years | +137.9% | -1.0% |
BMY Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.4% | at low | -8.8% | +6.7% |
| 5 y | 5-year | -8.6% | +114.9% | -24.8% | +38.2% |
| alltime | all time | -8.6% | +561.2% | -24.8% | +1974.5% |
Bristol-Myers Squibb Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.76 B(-6.6%) |
| Jun 2024 | - | $7.24 B(-2.4%) |
| Mar 2024 | - | $7.42 B(+8.6%) |
| Dec 2023 | $26.12 B(-3.0%) | $6.83 B(+5.0%) |
| Sep 2023 | - | $6.50 B(+0.8%) |
| Jun 2023 | - | $6.45 B(+1.7%) |
| Mar 2023 | - | $6.34 B(-11.0%) |
| Dec 2022 | $26.92 B(-3.5%) | $7.12 B(+5.2%) |
| Sep 2022 | - | $6.77 B(+3.7%) |
| Jun 2022 | - | $6.53 B(+0.3%) |
| Mar 2022 | - | $6.51 B(-10.7%) |
| Dec 2021 | $27.91 B(-2.3%) | $7.29 B(-0.3%) |
| Sep 2021 | - | $7.31 B(+5.9%) |
| Jun 2021 | - | $6.91 B(+8.0%) |
| Mar 2021 | - | $6.40 B(-28.9%) |
| Dec 2020 | $28.57 B(+135.1%) | $9.00 B(+34.4%) |
| Sep 2020 | - | $6.70 B(+2.4%) |
| Jun 2020 | - | $6.54 B(+3.2%) |
| Mar 2020 | - | $6.34 B(+29.5%) |
| Dec 2019 | $12.15 B(+10.7%) | $4.89 B(+99.1%) |
| Sep 2019 | - | $2.46 B(+1.4%) |
| Jun 2019 | - | $2.42 B(+2.0%) |
| Mar 2019 | - | $2.38 B(-15.1%) |
| Dec 2018 | $10.98 B(-3.0%) | $2.80 B(+17.4%) |
| Sep 2018 | - | $2.38 B(-33.1%) |
| Jun 2018 | - | $3.57 B(+59.9%) |
| Mar 2018 | - | $2.23 B(-33.2%) |
| Dec 2017 | $11.32 B(+13.3%) | $3.34 B(+22.5%) |
| Sep 2017 | - | $2.72 B(-5.0%) |
| Jun 2017 | - | $2.87 B(+20.0%) |
| Mar 2017 | - | $2.39 B(-18.6%) |
| Dec 2016 | $9.99 B(-8.5%) | $2.94 B(+27.6%) |
| Sep 2016 | - | $2.30 B(-9.0%) |
| Jun 2016 | - | $2.53 B(+13.6%) |
| Mar 2016 | - | $2.23 B(-35.8%) |
| Dec 2015 | $10.92 B(+6.7%) | $3.47 B(+47.1%) |
| Sep 2015 | - | $2.36 B(-22.2%) |
| Jun 2015 | - | $3.03 B(+46.1%) |
| Mar 2015 | - | $2.07 B(-37.1%) |
| Dec 2014 | $10.23 B(+15.8%) | $3.29 B(+48.9%) |
| Sep 2014 | - | $2.21 B(-14.9%) |
| Jun 2014 | - | $2.60 B(+22.0%) |
| Mar 2014 | - | $2.13 B(-7.6%) |
| Dec 2013 | $8.84 B(-2.7%) | $2.31 B(+9.6%) |
| Sep 2013 | - | $2.10 B(-9.0%) |
| Jun 2013 | - | $2.31 B(+9.4%) |
| Mar 2013 | - | $2.11 B(-18.5%) |
| Dec 2012 | $9.08 B(+0.8%) | $2.59 B(+18.2%) |
| Sep 2012 | - | $2.19 B(+0.1%) |
| Jun 2012 | - | $2.19 B(+4.0%) |
| Mar 2012 | - | $2.10 B(-16.4%) |
| Dec 2011 | $9.01 B(+9.1%) | $2.52 B(+14.7%) |
| Sep 2011 | - | $2.20 B(-0.9%) |
| Jun 2011 | - | $2.22 B(+6.7%) |
| Mar 2011 | - | $2.08 B(-10.0%) |
| Dec 2010 | $8.26 B(+0.3%) | $2.31 B(+18.6%) |
| Sep 2010 | - | $1.95 B(-1.6%) |
| Jun 2010 | - | $1.98 B(-2.1%) |
| Mar 2010 | - | $2.02 B(+2.1%) |
| Dec 2009 | $8.23 B(+11.6%) | $1.98 B(-2.4%) |
| Sep 2009 | - | $2.03 B(-1.5%) |
| Jun 2009 | - | $2.06 B(-4.7%) |
| Mar 2009 | - | $2.16 B(+562.9%) |
| Dec 2008 | $7.38 B(-23.2%) | $326.00 M(-86.4%) |
| Sep 2008 | - | $2.40 B(+6.9%) |
| Jun 2008 | - | $2.25 B(+0.6%) |
| Mar 2008 | - | $2.23 B(-26.8%) |
| Dec 2007 | $9.60 B(+5.2%) | $3.05 B(+36.0%) |
| Sep 2007 | - | $2.25 B(+1.5%) |
| Jun 2007 | - | $2.21 B(+0.9%) |
| Mar 2007 | - | $2.19 B(-6.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $9.13 B(0.0%) | $2.34 B(+5.1%) |
| Sep 2006 | - | $2.23 B(-1.8%) |
| Jun 2006 | - | $2.27 B(-0.4%) |
| Mar 2006 | - | $2.28 B(-4.5%) |
| Dec 2005 | $9.13 B(+2.3%) | $2.39 B(+3.8%) |
| Sep 2005 | - | $2.30 B(+1.0%) |
| Jun 2005 | - | $2.28 B(+5.9%) |
| Mar 2005 | - | $2.15 B(-13.5%) |
| Dec 2004 | $8.93 B(+7.4%) | $2.49 B(+16.5%) |
| Sep 2004 | - | $2.14 B(-1.5%) |
| Jun 2004 | - | $2.17 B(+2.2%) |
| Mar 2004 | - | $2.13 B(-9.6%) |
| Dec 2003 | $8.31 B(+11.3%) | $2.35 B(+14.8%) |
| Sep 2003 | - | $2.05 B(+1.1%) |
| Jun 2003 | - | $2.02 B(+7.1%) |
| Mar 2003 | - | $1.89 B(-13.4%) |
| Dec 2002 | $7.47 B(+1.3%) | $2.18 B(+20.7%) |
| Sep 2002 | - | $1.81 B(-0.1%) |
| Jun 2002 | - | $1.81 B(+8.1%) |
| Mar 2002 | - | $1.67 B(-21.0%) |
| Dec 2001 | $7.38 B(-1.3%) | $2.12 B(+26.8%) |
| Sep 2001 | - | $1.67 B(-11.4%) |
| Jun 2001 | - | $1.89 B(+5.0%) |
| Mar 2001 | - | $1.80 B(+35.0%) |
| Dec 2000 | $7.47 B(-3.9%) | $1.33 B(-34.3%) |
| Sep 2000 | - | $2.02 B(-21.5%) |
| Jun 2000 | - | $2.58 B(+31.0%) |
| Mar 2000 | - | $1.97 B(-9.4%) |
| Dec 1999 | $7.78 B(+6.0%) | $2.17 B(+17.2%) |
| Sep 1999 | - | $1.85 B(-23.0%) |
| Jun 1999 | - | $2.40 B(+7.4%) |
| Mar 1999 | - | $2.24 B(+170.2%) |
| Dec 1998 | $7.33 B(-12.6%) | $829.00 M(-61.3%) |
| Sep 1998 | - | $2.14 B(-2.9%) |
| Jun 1998 | - | $2.21 B(+2.3%) |
| Mar 1998 | - | $2.16 B(-8.9%) |
| Dec 1997 | $8.39 B(+9.4%) | $2.37 B(+19.2%) |
| Sep 1997 | - | $1.99 B(-4.1%) |
| Jun 1997 | - | $2.07 B(+5.2%) |
| Mar 1997 | - | $1.97 B(-5.4%) |
| Dec 1996 | $7.67 B(+10.1%) | $2.08 B(+15.0%) |
| Sep 1996 | - | $1.81 B(-6.5%) |
| Jun 1996 | - | $1.93 B(+4.9%) |
| Mar 1996 | - | $1.84 B(-8.4%) |
| Dec 1995 | $6.96 B(+16.7%) | $2.01 B(+24.9%) |
| Sep 1995 | - | $1.61 B(-8.4%) |
| Jun 1995 | - | $1.76 B(+11.5%) |
| Mar 1995 | - | $1.58 B(-7.7%) |
| Dec 1994 | $5.97 B(-5.1%) | $1.71 B(+23.9%) |
| Sep 1994 | - | $1.38 B(-10.2%) |
| Jun 1994 | - | $1.54 B(+14.5%) |
| Mar 1994 | - | $1.34 B(-38.1%) |
| Dec 1993 | $6.29 B(-5.2%) | $2.17 B(+60.1%) |
| Sep 1993 | - | $1.35 B(-7.3%) |
| Jun 1993 | - | $1.46 B(+11.2%) |
| Mar 1993 | - | $1.31 B(-39.3%) |
| Dec 1992 | $6.63 B(+16.2%) | $2.16 B(+39.6%) |
| Sep 1992 | - | $1.55 B(+0.8%) |
| Jun 1992 | - | $1.53 B(+10.1%) |
| Mar 1992 | - | $1.39 B(-15.4%) |
| Dec 1991 | $5.71 B(+8.1%) | $1.65 B(+24.2%) |
| Sep 1991 | - | $1.32 B(-3.6%) |
| Jun 1991 | - | $1.38 B(+0.9%) |
| Mar 1991 | - | $1.36 B(-13.1%) |
| Dec 1990 | $5.28 B(-6.5%) | $1.57 B(+25.8%) |
| Sep 1990 | - | $1.25 B(+0.3%) |
| Jun 1990 | - | $1.24 B(+1.4%) |
| Mar 1990 | - | $1.23 B |
| Dec 1989 | $5.65 B(+25.8%) | - |
| Dec 1988 | $4.49 B(+13.6%) | - |
| Dec 1987 | $3.95 B | - |
FAQ
- What is Bristol-Myers Squibb annual total operating expenses?
- What is the all time high annual operating expenses for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual operating expenses year-on-year change?
- What is Bristol-Myers Squibb quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly operating expenses year-on-year change?
What is Bristol-Myers Squibb annual total operating expenses?
The current annual operating expenses of BMY is $26.12 B
What is the all time high annual operating expenses for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual total operating expenses is $28.57 B
What is Bristol-Myers Squibb annual operating expenses year-on-year change?
Over the past year, BMY annual total operating expenses has changed by -$800.00 M (-2.97%)
What is Bristol-Myers Squibb quarterly total operating expenses?
The current quarterly operating expenses of BMY is $6.76 B
What is the all time high quarterly operating expenses for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly total operating expenses is $9.00 B
What is Bristol-Myers Squibb quarterly operating expenses year-on-year change?
Over the past year, BMY quarterly total operating expenses has changed by -$66.00 M (-0.97%)